Popular Articles
Cellulite Cream

Jazz Pharmaceuticals To Present Data From First Phase III Study Of Sodium Oxybate In Patients With Fibromyalgia
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that data from the company"s first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented this week during the Associated Professional Sleep Societies (APSS) 2009 Annual Meeting in Seattle, Washington and also during the European League Against Rheumatism (EULAR) Congress in Copenhagen, Denmark.
generic viagra online
Survival Predictors May Help Customize Treatment Options For Men With Metastatic Prostate Cancer
Four risk factors that help predict how long men may survive with metastatic prostate cancer could help doctors choose more effective treatments, according to a study led by researchers in the Duke Comprehensive Cancer Center.
News of the day
A Cancer Gene Switch For Repairing Damaged DNA
Scientists at the Medical Research Council Laboratory of Molecular Biology uncover how an important cancer gene, BRCA1, works by increasing the accuracy with which broken DNA is repaired. Women who inherit a faulty version of the BRCA1 gene are at a higher risk of developing breast or ovarian cancer.
Oncology

NMC To Develop Practical Guidelines For Professionals On Whistle-blowing

The NMC has started work to improve its advice and information on whistle-blowing for nurses and midwives. Representatives from the Royal College of Nursing (RCN), the Royal College of Midwives (RCM), UNISON, Unite/CPHVA and Public Concern at Work, met with the NMC yesterday to discuss how anxieties about future career prospects, upsetting workmates and management and breaching their Code of professional conduct, can sometimes discourage nurses and midwives from reporting concerns. Clearer signposts to existing advice and information on whistle-blowing were strongly recommended along with the need to raise awareness amongst nurses, midwives and their employers about existing safeguards for whistleblowers and the responsibilities of employers contained within the Public Interest Disclosure Act 1998. Commenting on the meeting, Christina McKenzie, NMC Head of Midwifery, said: "We are grateful to our colleagues for this first opportunity to exchange information experience and expertise on this topic. As a result of this meeting, we will develop information for nurses and midwives setting out the options for escalating concerns appropriately, in a way that is safe for patients and the public, and in a way that will not bring them into conflict with their Code." There was also consensus about the need to involve other stakeholders including patient"s groups and employers of nurses and midwives across the NHS, independent and voluntary sectors. Christina added: "We are addressing the matter with urgency but we are mindful of the need for proper, considered engagement with key stakeholders. Regulatory activity in this area will require responsible action by all the partners and this will need to be explored in depth in order to achieve all our goals." Nursing & Midwifery Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):